136 related articles for article (PubMed ID: 7001490)
1. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
Cooper AJ; Magnus RV
Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
[TBL] [Abstract][Full Text] [Related]
2. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
[TBL] [Abstract][Full Text] [Related]
3. Controlled study of the effect of pyritinol in geronto-patients.
Slánská J
Act Nerv Super (Praha); 1990 Mar; 32(1):57-8. PubMed ID: 2363339
[No Abstract] [Full Text] [Related]
4. [Pyritinol in the ambulatory geriatric patient. A placebo controled combined study].
Gonçalves N
Med Welt; 1979 Mar; 30(13):494-8. PubMed ID: 372727
[No Abstract] [Full Text] [Related]
5. Contribution to the search for vigilance-indicative EEG variables. Results of a controlled, double-blind study with pyritinol in elderly patients with symptoms of mental dysfunction.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Mar; 19(2):75-83. PubMed ID: 3517890
[TBL] [Abstract][Full Text] [Related]
6. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
[TBL] [Abstract][Full Text] [Related]
7. Pyritinol hydrochloride (encephabol) and senile dementia.
Flood MK
Br Med J; 1979 Apr; 1(6171):1148. PubMed ID: 376047
[No Abstract] [Full Text] [Related]
8. Use of encephabol in anaesthesia and post-anaesthesia resuscitation.
Papathéodossiou N
Anaesthesist; 1979 Nov; 28(11):530-2. PubMed ID: 525751
[TBL] [Abstract][Full Text] [Related]
9. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T
J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681
[TBL] [Abstract][Full Text] [Related]
10. Accelerated remission of the alcoholic organic brain syndrome with EMD 21657. Double-blind clinical and psychometric trials.
Saletu M; Grünberger J; Saletu B; Mader R
Arzneimittelforschung; 1978; 28(9):1525-7. PubMed ID: 383103
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with Encephabol (author's transl)].
Glatzel J
Med Klin; 1976 Nov; 71(45):1958-61. PubMed ID: 792665
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of pyritinol on sequelae of head injuries.
Kitamura K
J Int Med Res; 1981; 9(3):215-21. PubMed ID: 7016627
[TBL] [Abstract][Full Text] [Related]
13. [Pyrithioxin (Encephabol) in the treatment of patients with organic psychosyndrom in involution. Clinical, EEG and experimental psychological study (author's transl)].
Misurec J; Sláma B; Náhunek K
Cesk Psychiatr; 1976 Feb; 72(1):14-23. PubMed ID: 773551
[No Abstract] [Full Text] [Related]
14. Pyritinol hydrochloride and cognitive functions: influence on children in slow learner classes.
Wälti U; Kuenzler M; Schild J; Vassella F; Pavlincova E; Bircher J; Herschkowitz N
Pediatr Res; 1975 Sep; 9(9):717-21. PubMed ID: 1105370
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
Otomo E; Araki G; Mori A; Kurihara M
Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
[TBL] [Abstract][Full Text] [Related]
16. [Our experience with pyritinol in patient with brain concussion].
Bystrický Z; Zouhar A; Janík B
Med Welt; 1977 Apr; 28(13):643-6. PubMed ID: 323638
[No Abstract] [Full Text] [Related]
17. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
[TBL] [Abstract][Full Text] [Related]
18. [Dose-effect relationship of orally administered Pyritinol in the chronic organic brain syndrome (author's transl)].
Glatzel J
Med Klin; 1978 Aug; 73(31):1117-21. PubMed ID: 672767
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyritinol-GCl on blood flow and oxidative metabolism of the brain in patients with dementia.
Hoyer S; Oesterreich K; Stoll KD
Arzneimittelforschung; 1977; 27(3):671-4. PubMed ID: 577444
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical studies on the mechanism of action of pyritinol.
Greiner HE; Haase AF; Seyfried CA
Pharmacopsychiatry; 1988 Aug; 21 Suppl 1():26-32. PubMed ID: 2905813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
